Of the two TEC-VAL contracts called within the Biosanitary Revitalization Plan Aid Program this year, of which only one was covered, IDIVAL once again announces a temporary internship labor contract for the training of support technicians in the Testing Unit Valdecilla clinics (“Tec-Val” Program). The purpose of this program is to promote the professional practice […]
On December 17, Antonio Fernández, M.D. Director, Business Development & Government Affairs of Johnson & Johnson, gives an online presentation under the title “Vaccines for COVID. A new challenge, a new development ”. Antonio Fernández has a degree in Medicine from the University of Navarra and a graduate of the Executive Development Program of the […]
Recently, a multicenter retrospective has been published in the American Journal of Transplantation in which six of the seven hospitals that perform lung transplantation in Spain have participated and which are the following: Vall d'Hebron (Barcelona), La Fe (Valencia) , Marqués de Valdecilla (Santander), Reina Sofía (Córdoba), Puerta de Hierro (Madrid), October 12 (Madrid), and […]
The Marqués de Valdecilla University Hospital Rheumatology Unit, in collaboration with the Valdecilla Health Research Institute (IDIVAL), has launched a study to determine the relationship between immunological inflammatory diseases and SARS-CoV-2. Developed by doctors Ricardo Blanco, Miguel Ángel González-Gay and David Martínez-López, the objectives of this research in patients with rheumatological diseases with an immune […]
On 3rd and 4th September we invite you to Trieste at EuroBioHighTech 2020, the satellite event of the European Science Open Forum, the main European research event. EBHT is a unique event dedicated to Smart Health and Innovation for Businesses. The main players are: universities, investors, innovative companies and public institutions operating in the field […]
IDIVAL presents the award for his research career to Dr. Luis Rojas Marcos and the award for health cooperation for development to Dr. Pedro Cavadas. The award ceremony will take place during the XIII Inter-regional Meeting on Legal Protection of the Patient organized by the University Menéndez Pelayo International and directed by Jorge Tomillo, Professor […]
The Marqués de Valdecilla University Hospital has been one of the 3 Spanish hospitals selected to participate in an international study investigating a vaccine, Ad26COVS, against the SARS-CoV-2 coronavirus, which is responsible for the COVID-19 disease. Thanks to the collaboration of healthy volunteers, the aim is to evaluate the immune response to different doses of […]
The ISCIII through the extraordinary call for research projects on SARS-COV-2 and the Covid-19 disease has financed the project “Seroprevalence against SARS-CoV-2 in pregnant women and newborns” directed by Dr. Cabero -Head of the Pediatrics Service- and Dr. Llorca -Professor of Preventive Medicine and Public Health-. This project aims to know the impact that COVID-19 […]
The multidisciplinary work team formed by the group of Cell Signaling and Therapeutic Targets in Cancer of IDIVAL; the Optics group of the University of Cantabria (UC) and the Neurosurgery service of the Marqués de Valdecilla University Hospital (HUMV); Together with the company Fotoglass, specialized in biomedical optics, a spin off of UC, they have […]
The research group "Melatonin and Breast Cancer" of IDIVAL has recently published in the journal Biomedicines, with impact factor Q1, the article "Melatonin as a Radio-Sensitizer in Cancer". Radiotherapy is one of the treatments of choice in many types of cancer. Adjuvant treatments to radiotherapy try, on one hand, to enhance the response of tumor […]
